Selection for international MATWIN board

Published on 06/10/2020

Digital meeting
13-14 October, 2020

MATWIN (Maturation & Accelerating Translation within Industry) is an innovation platform that aims to accelerate transfer of oncology innovation from academia & SMEs to clinical development. 13 Pharma partners and numerous academic opinion leaders review proposals for partnership opportunities that offer most promise for patient well being. ENYO Pharma project is selected for a pitch to participating VC investors for start-up funds.

Read next in 'Events'

• The 2024 international workshop on Alport syndrome
• ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
• 6th CKD Summit – Chronic Kidney Disease Drug Development
• ASN Kidney Week
• Alport Connect 2023, the annual Alport syndrome patient and family meeting in US